Human Immunodeficiency Virus (HIV) Clinical Trials

14 recruiting

Human Immunodeficiency Virus (HIV) Trials at a Glance

15 actively recruiting trials for human immunodeficiency virus (hiv) are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Cape Town, Johannesburg, and Durban. Lead sponsors running human immunodeficiency virus (hiv) studies include Merck Sharp & Dohme LLC, Wake Forest University Health Sciences, and Johns Hopkins University.

Browse human immunodeficiency virus (hiv) trials by phase

Treatments under study

About Human Immunodeficiency Virus (HIV) Clinical Trials

Looking for clinical trials for Human Immunodeficiency Virus (HIV)? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Human Immunodeficiency Virus (HIV) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Human Immunodeficiency Virus (HIV) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 2

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 3

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Phase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Smoking CessationHuman Immunodeficiency Virus (HIV)
New York University500 enrolled1 locationNCT06598397
Recruiting
Not Applicable

Persuasive Health Communication Intervention for HIV/HCV

Human Immunodeficiency Virus (HIV)Hepatitis C (HCV)
University of South Florida2,000 enrolled1 locationNCT05968573
Recruiting
Phase 3

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled29 locationsNCT07071623
Recruiting
Not Applicable

The Trans-Led Care Study

Substance AbuseSubstance AddictionSubstance Use Disorder (SUD)+2 more
Illinois Institute of Technology124 enrolled1 locationNCT06880705
Recruiting
Not Applicable

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

Cervical CancerHuman Papillomavirus (HPV) InfectionHuman Immunodeficiency Virus (HIV) Infection
University of California, Irvine420 enrolled1 locationNCT07209917
Recruiting

Voluntary HIV Screening in the General Population in France

Human Immunodeficiency Virus (HIV)
Université de Reims Champagne-Ardenne1,000 enrolled1 locationNCT07418385
Recruiting
Not Applicable

Strategies to AchieVe Viral Suppression for Youth With HIV

Human Immunodeficiency Virus (HIV) Infection
Johns Hopkins University288 enrolled1 locationNCT06886971
Recruiting
Not Applicable

Quitting Matters Human Immunodeficiency Virus Hybrid Trial

Smoking CessationCancer PreventionHuman Immunodeficiency Virus (HIV)+4 more
Wake Forest University Health Sciences314 enrolled1 locationNCT06883097
Recruiting
Phase 2

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Cardiovascular Risk FactorHuman Immunodeficiency Virus (HIV)
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled1 locationNCT07030920
Recruiting
Not Applicable

Project neuroARTEMIS

DepressionStimulant UseHuman Immunodeficiency Virus (HIV)
Wake Forest University Health Sciences189 enrolled1 locationNCT06814275
Recruiting
Not Applicable

e-HERO: Ending the HIV Epidemic in Rural Oklahoma

Human Immunodeficiency Virus (HIV)
Northern Arizona University200 enrolled1 locationNCT05664802
Recruiting

The Enhanced Advance care planning and life Review Longitudinal Intervention Community Outreach (EARLI-comm) Project

CancerFrailtyHuman Immunodeficiency Virus (HIV)+1 more
University of New South Wales120 enrolled1 locationACTRN12624000218594
Recruiting

Effects of a supervised exercise program on the physical fitness, immunological function and quality of life of Human immunodeficiency virus (HIV)-Infected Patients.

Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)
State University of Rio de Janeiro300 enrolled1 locationACTRN12610000683033